In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1845 News Items found
Dr. Jun Mao with patient
ASCO 2020: Using Acupuncture to Treat Pain in Cancer Survivors

During the upcoming ASCO Virtual Scientific Program, MSK Chief of Integrative Medicine, Jun J. Mao, MD, MSCE will be presenting a new study comparing the effectiveness of electro-acupuncture (EA) and auricular acupuncture (AA) versus usual care (UC) for chronic musculoskeletal pain in cancer survivors.
Nitya Raj
6 Tips for a Successful Telemedicine Visit with Your Doctor

Learn the keys to a successful telemedicine visit from a cancer specialist at Memorial Sloan Kettering.
ASCO20 Virtual Scientific Program
ASCO 2020: MSK Experts Featured at the Virtual Scientific Program

Thousands of oncology experts from around the world will tune in May 29-31 for the American Society of Clinical Oncology’s (ASCO) Virtual Scientific Program. MSK physicians and scientists are involved in notable research to be presented at the meeting.
In the Lab
X and Y chromosomes in mice
Breaking Up Is Hard to Do (Especially for Sex Chromosomes)

One’s big, one’s small. Somehow, they make it work.
Jeffrey Drebin, MD, PhD
Creating a Safe Space for Cancer Surgery

Concerns around COVID-19 are common in the general population, but cancer patients are also balancing questions about what the pandemic means for their treatment, prognosis, and vulnerability to the virus.
Feature
Two gloved hands opening a drawer in a laboratory.
Double Trouble: Researchers Find Many Cancers Carry Two Mutations in the Same Gene

Discovery reveals that the genetic causes of cancer may be more complicated than previously thought.
In Brief
A fluorescent image of cells undergoing differentiation in a mouse model.
Cancer Stem Cells’ Reliance on a Key Amino Acid Could Be an Exploitable Weakness

The discovery links metabolism to the way cancer stem cells form tumors.
Alexander Drilon, MD
Targeted Therapy Selpercatinib Approved for Lung and Thyroid Cancers With RET Gene Mutations or Fusions

The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to selpercatinib (Retevmo™) for lung and thyroid cancers with RET (REarranged during Transfection) gene mutations or fusions.
Katherine High, MD
MSK Science Spotlight: Gene Therapy for Genetic Disease

The May 20 installment of “MSK Science Spotlight” will feature guest speaker, Katherine High, MD, Professor Emerita, Perelman School of Medicine of the University of Pennsylvania; Co-founder and former President and Head of R&D, Spark Therapeutics.
In the Clinic
Lisa Toth donates plasma with help from Anli Chang
Exploring the Potential of Convalescent Plasma for COVID-19 Treatment

Learn about a clinical trial at Memorial Sloan Kettering that is using plasma donated by MSK employees who have recovered from COVID-19.